Annual FCF
-$10.02 M
-$1.92 M-23.68%
31 December 2023
Summary:
Scinai Immunotherapeutics annual free cash flow is currently -$10.02 million, with the most recent change of -$1.92 million (-23.68%) on 31 December 2023. During the last 3 years, it has risen by +$14.45 million (+59.05%). SCNI annual FCF is now -692.83% below its all-time high of -$1.26 million, reached on 01 December 2013.SCNI Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$2.04 M
-$278.00 K-15.76%
30 September 2024
Summary:
Scinai Immunotherapeutics quarterly free cash flow is currently -$2.04 million, with the most recent change of -$278.00 thousand (-15.76%) on 30 September 2024. Over the past year, it has increased by +$200.00 thousand (+8.92%). SCNI quarterly FCF is now -663.08% below its all-time high of -$267.60 thousand, reached on 01 September 2016.SCNI Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$6.73 M
+$200.00 K+2.89%
30 September 2024
Summary:
Scinai Immunotherapeutics TTM free cash flow is currently -$6.73 million, with the most recent change of +$200.00 thousand (+2.89%) on 30 September 2024. Over the past year, it has increased by +$2.69 million (+28.58%). SCNI TTM FCF is now -1279.66% below its all-time high of -$487.80 thousand, reached on 01 March 2014.SCNI TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SCNI Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.7% | +8.9% | +28.6% |
| 3 y3 years | +59.0% | - | - |
| 5 y5 years | +58.9% | - | - |
SCNI Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -32.4% | +59.0% | -136.6% | +43.8% | -313.9% | +32.8% |
| 5 y | 5 years | -32.4% | +59.0% | -136.6% | +43.8% | -313.9% | +32.8% |
| alltime | all time | -692.8% | +59.0% | -663.1% | +83.2% | -1279.7% | +68.7% |
Scinai Immunotherapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.04 M(+15.8%) | -$6.73 M(-2.9%) |
| June 2024 | - | -$1.76 M(+20.4%) | -$6.93 M(-17.7%) |
| Mar 2024 | - | -$1.47 M(+0.4%) | -$8.42 M(-16.0%) |
| Dec 2023 | -$10.02 M(+23.7%) | -$1.46 M(-34.9%) | -$10.02 M(+6.3%) |
| Sept 2023 | - | -$2.24 M(-31.1%) | -$9.42 M(+2.8%) |
| June 2023 | - | -$3.25 M(+6.1%) | -$9.16 M(-4.0%) |
| Mar 2023 | - | -$3.06 M(+255.2%) | -$9.54 M(+17.8%) |
| Dec 2022 | -$8.10 M(+7.1%) | -$863.00 K(-56.5%) | -$8.10 M(+11.9%) |
| Sept 2022 | - | -$1.98 M(-45.4%) | -$7.24 M(+37.7%) |
| June 2022 | - | -$3.63 M(+123.2%) | -$5.26 M(+223.2%) |
| Mar 2022 | - | -$1.63 M(-74.9%) | -$1.63 M(-89.7%) |
| Dec 2021 | -$7.57 M(-69.1%) | - | - |
| Dec 2020 | -$24.47 M(+0.3%) | - | - |
| Dec 2019 | -$24.40 M(+13.6%) | - | - |
| June 2019 | - | -$6.49 M(+43.3%) | -$15.74 M(-26.4%) |
| Mar 2019 | - | -$4.53 M(+129.9%) | -$21.39 M(-0.4%) |
| Dec 2018 | -$21.49 M | -$1.97 M(-28.5%) | -$21.49 M(+2.2%) |
| Sept 2018 | - | -$2.75 M(-77.3%) | -$21.01 M(+8.4%) |
| June 2018 | - | -$12.14 M(+162.8%) | -$19.39 M(+137.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$4.62 M(+208.8%) | -$8.15 M(+94.7%) |
| Dec 2017 | -$4.19 M(+66.6%) | -$1.50 M(+33.0%) | -$4.19 M(+28.7%) |
| Sept 2017 | - | -$1.13 M(+23.4%) | -$3.26 M(+35.8%) |
| June 2017 | - | -$911.70 K(+39.1%) | -$2.40 M(+3.6%) |
| Mar 2017 | - | -$655.20 K(+16.2%) | -$2.31 M(-8.0%) |
| Dec 2016 | -$2.51 M(-4.7%) | -$563.70 K(+110.7%) | -$2.51 M(-7.8%) |
| Sept 2016 | - | -$267.60 K(-67.7%) | -$2.73 M(-11.2%) |
| June 2016 | - | -$827.70 K(-3.3%) | -$3.07 M(+2.3%) |
| Mar 2016 | - | -$855.70 K(+10.4%) | -$3.00 M(+13.7%) |
| Dec 2015 | -$2.64 M(+35.2%) | -$775.00 K(+27.0%) | -$2.64 M(+12.3%) |
| Sept 2015 | - | -$610.20 K(-19.6%) | -$2.35 M(+6.9%) |
| June 2015 | - | -$759.40 K(+53.7%) | -$2.20 M(+12.2%) |
| Mar 2015 | - | -$494.10 K(+1.6%) | -$1.96 M(+0.3%) |
| Dec 2014 | -$1.95 M(+54.5%) | -$486.30 K(+6.3%) | -$1.95 M(+33.2%) |
| Sept 2014 | - | -$457.50 K(-12.2%) | -$1.47 M(+45.4%) |
| June 2014 | - | -$520.80 K(+6.8%) | -$1.01 M(+106.8%) |
| Mar 2014 | - | -$487.80 K | -$487.80 K |
| Dec 2013 | -$1.26 M(-35.4%) | - | - |
| Dec 2012 | -$1.96 M(-39.9%) | - | - |
| Dec 2011 | -$3.26 M | - | - |
FAQ
- What is Scinai Immunotherapeutics annual free cash flow?
- What is the all time high annual FCF for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics annual FCF year-on-year change?
- What is Scinai Immunotherapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly FCF year-on-year change?
- What is Scinai Immunotherapeutics TTM free cash flow?
- What is the all time high TTM FCF for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics TTM FCF year-on-year change?
What is Scinai Immunotherapeutics annual free cash flow?
The current annual FCF of SCNI is -$10.02 M
What is the all time high annual FCF for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high annual free cash flow is -$1.26 M
What is Scinai Immunotherapeutics annual FCF year-on-year change?
Over the past year, SCNI annual free cash flow has changed by -$1.92 M (-23.68%)
What is Scinai Immunotherapeutics quarterly free cash flow?
The current quarterly FCF of SCNI is -$2.04 M
What is the all time high quarterly FCF for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high quarterly free cash flow is -$267.60 K
What is Scinai Immunotherapeutics quarterly FCF year-on-year change?
Over the past year, SCNI quarterly free cash flow has changed by +$200.00 K (+8.92%)
What is Scinai Immunotherapeutics TTM free cash flow?
The current TTM FCF of SCNI is -$6.73 M
What is the all time high TTM FCF for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high TTM free cash flow is -$487.80 K
What is Scinai Immunotherapeutics TTM FCF year-on-year change?
Over the past year, SCNI TTM free cash flow has changed by +$2.69 M (+28.58%)